“The endeavour of the Central government is to provide affordable and quality healthcare for all and to boost indigenous pharmaceutical sector through Make in India. In this direction, the Cabinet has given approval for 100% FDI under automatic route for manufacturing of medical devices,” said Union Minister D.V. Sadananda Gowda here on Thursday.
The Minister for Chemicals and Fertilisers, and Statistics and Programme Implementation was addressing the media during a curtain raiser for ‘India Pharma 2019 & India Medical Device 2019’.
Fourth conclave
The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilisers and the Federation of Indian Chambers of Commerce & Industry (FICCI) is organising the 4th international conference on pharmaceutical and medical device sector on February 18-19, 2019 in Bengaluru. The theme for India Pharma 2019 is ‘Enabling Quality Affordable Healthcare’ and that of India Medical Device 2019 is ‘Med-Tech India: Gearing up for Ayushman Bharat’.
Mr. Gowda said that the flagship event would bring key stakeholders of the pharma and medical devices sectors under one roof and provide an opportunity to discuss the government policy and challenges facing the Industry. Government is striving to make the processes in the sector as transparent and easy as possible.
Minister of State Chemicals and Fertilisers Mansukh Mandaviya noted that the event will have brainstorming sessions on various aspects of pharmaceuticals and medical device sector and in its 4th edition the event will help in resolving the bottlenecks of growth in the sectors. He invited the industry, media and the healthcare fraternity to participate in a big way at the event.
Speaking on the rationale of holding the annual conference, Secretary (Pharmaceuticals), J.P. Prakash said that the event is held annually to get new and innovative ideas from all stakeholders in the conference. “This helps the department to prepare the annual action plan for the pharma and medical device sectors. During the conference, the annual action taken report on the issues raised at the last edition of the event along with new areas of concern will be discussed, he added.
At the main event in Bengaluru, over 150 CEOs of the global pharma and medical device industry are expected to participate.
International drug regulators from 15 countries have been invited to the event for interaction with Indian drug regulators and industry regulatory officers. Ambassadors and commercial counsellors of more than 50 countries have been invited for close interaction with government of India and participating Industry.
